For sales

Highlights from the Week of 25th May – 01st June in the world of pharma and healthcare!

Highlights from the week of 25th May - 01st June AbbVie ( FDA, Approval ) AbbVie's DECNUPAZ gains FDA approval to treat BPDCN, a hematologic malignancy with limited treatment options AstraZeneca ( FDA, Approval ) FDA gives approval to AstraZeneca's IMFINZI in combination with BCG induction and maintenance therapy for the treatment of adult patients with BCG-naïve, high-risk NMIBC Shionogi ( FDA, Approval ) Shionogi's XOCOVA receives FDA approval for post-exposure prophylaxis of COVID-19 in adults and adolescents 12 years and older Mannkind ( FDA, Approval ) MannKind's AFREZZA inhalation powder is now FDA approved for use in children and adolescents aged 6 years and older with type 1 and 2 diabetes All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.